1. Home
  2. ARCT vs IDE Comparison

ARCT vs IDE Comparison

Compare ARCT & IDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arcturus Therapeutics Holdings Inc.

ARCT

Arcturus Therapeutics Holdings Inc.

HOLD

Current Price

$8.42

Market Cap

233.8M

Sector

Health Care

ML Signal

HOLD

Logo Voya Infrastructure Industrials and Materials Fund of Beneficial Interest

IDE

Voya Infrastructure Industrials and Materials Fund of Beneficial Interest

HOLD

Current Price

$14.25

Market Cap

205.1M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARCT
IDE
Founded
2013
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
233.8M
205.1M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
ARCT
IDE
Price
$8.42
$14.25
Analyst Decision
Buy
Analyst Count
11
0
Target Price
$38.44
N/A
AVG Volume (30 Days)
388.5K
59.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
8.83%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$152,310,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.85
$8.75
52 Week High
$24.14
$14.30

Technical Indicators

Market Signals
Indicator
ARCT
IDE
Relative Strength Index (RSI) 65.18 77.64
Support Level $5.93 $13.23
Resistance Level $13.78 N/A
Average True Range (ATR) 0.46 0.15
MACD 0.09 -0.01
Stochastic Oscillator 84.37 90.41

Price Performance

Historical Comparison
ARCT
IDE

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.

About IDE Voya Infrastructure Industrials and Materials Fund of Beneficial Interest

Voya Infrastructure, Industrials and Materials Fund is a diversified closed-end management investment company. The primary objective of this investment fund is to achieve total return by combining current income, capital gains, and capital appreciation. To achieve this objective, the fund invests in companies that own and/or operate infrastructure facilities in the infrastructure sector, as well as in a broad range of companies in the industrials and materials sectors that the Sub-Adviser believes will benefit from infrastructure building, renovation, expansion, and utilization.

Share on Social Networks: